Cargando…
Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development
Vaccines based on virus-like particles have proved their success in human health. More than 25 years after the approval of the first vaccine based on this technology, the substantial efforts to expand the range of applications and target diseases are beginning to bear fruit. The incursion of high-th...
Autores principales: | Rodríguez-Limas, William A, Sekar, Karthik, Tyo, Keith EJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127385/ https://www.ncbi.nlm.nih.gov/pubmed/23481378 http://dx.doi.org/10.1016/j.copbio.2013.02.008 |
Ejemplares similares
-
Molecular and process design for rotavirus-like particle production in Saccharomyces cerevisiae
por: Rodríguez-Limas, William A, et al.
Publicado: (2011) -
Virus-like Particle Vaccines and Platforms for Vaccine Development
por: Kheirvari, Milad, et al.
Publicado: (2023) -
Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
por: Caldeira, Jerri C., et al.
Publicado: (2020) -
N-Terminal-Based Targeted, Inducible Protein Degradation in Escherichia coli
por: Sekar, Karthik, et al.
Publicado: (2016) -
Virus like particles as a platform for cancer vaccine development
por: Ong, Hui Kian, et al.
Publicado: (2017)